Acadia Healthcare Company, Inc. Deferred Foreign Income Tax Expense (Benefit)
Acadia Healthcare Company, Inc. (ACHC) reported Deferred Foreign Income Tax Expense (Benefit) of $117.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-27
- Acadia Healthcare Company, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was $117.00K, a 68.21% decline from fiscal 2024.
- Acadia Healthcare Company, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $368.00K, a 33.93% decline from fiscal 2023.
- Acadia Healthcare Company, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was $557.00K, a 54.72% increase from fiscal 2022.
- Acadia Healthcare Company, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $360.00K, a 10.77% increase from fiscal 2021.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $117.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $368.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $557.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $360.00K 10-K · filed 2025-02-27 | |
| 2021-12-31 | $325.00K 10-K · filed 2024-02-28 | |
| 2020-12-31 | $6.10M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $152.00K 10-K · filed 2022-03-01 | $844.00K 10-K · filed 2020-02-28 |
| 2018-12-31 | $449.00K 10-K · filed 2021-02-26 | -$2.53M 10-K · filed 2019-03-01 |
| 2017-12-31 | -$215.00K 10-K · filed 2020-02-28 | |
| 2016-12-31 | -$17.92M 10-K · filed 2019-03-01 | |
| 2015-12-31 | -$2.37M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $4.20M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $495.00K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Concentra Group Holdings Parent, Inc. (CON) | United States | $4.417B | 19.11 |